Latest Stories
Recent Stories
WUHU, China, Oct. 19, 2025 /PRNewswire/ -- Chery Group and UNICEF today announced the renewal of their global partnership in education, launching a new three-year collaboration to transform the lives of children worldwide, especially the most vulnerable, by enabling them to access quality ed…
SHANGHAI, Oct. 19, 2025 /PRNewswire/ --Â Approved by the State Council, the 2025 Sustainable Global Leaders Conference opened on October 16 in Huangpu District, Shanghai. Centered around the theme "Joining Hands to Address Challenges: Global Action, Innovation, and Sustainable Growth," the Co…
CHENGDU, China  , Oct. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's trophoblas…
SHENZHEN, China, Oct. 19, 2025 /PRNewswire/ -- From October 15 to 19, 2025, SKYWORTH showcased its all-new Matte Screen Ultra TV series, alongside a selection of standout TV products, at the 138th China Import and Export Fair (Canton Fair), highlighting its innovation and brand strength to v…
SHANGHAI and HONG KONG, Oct. 19, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematolog…
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", C…
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), Â an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first discl…
-         The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule GLP-1 receptor (GLP-1R) agonist ASC30 in 65 participants with obesity or overweight.
Opening marks a major milestone in the nation's growth as a global trade and travel hub in Southeast Asia
In GATHER2 open-label extension study, IZERVAY reduced GA growth 37-40.5% vs. projected sham, with earlier intervention resulting in greater protection of retinal tissue area Â
SYDNEY, Oct. 19, 2025 /PRNewswire/ --Â The Brattle Group has welcomed Dr. Luke Wainscoat to its growing Sydney office as a Principal in the firm's Antitrust & Competition practice. An economist with 20 years of experience, Dr. Wainscoat advises clients on complex competition, regulatory, …
NEW YORK, Oct. 19, 2025 /PRNewswire/ --
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilima…
Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001.The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination the…
Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune Fortifying RNAs (UNIFYRsâ„¢) as a new class of RNA therapeutics poised to transform cancer treatment.
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients
BEIJING, Oct. 19, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum (FSF) 2025 will open on October 27 and run through October 30 in Beijing, organizers announced at a press briefing on Friday. Themed "Global Financial Development in an Era of Innovation, Transformation an…
LAS VEGAS, Oct. 19, 2025 /PRNewswire/ --Â Nassib Chamoun, CEO of Health Data Analytics Institute (HDAI), a leader in enterprise risk stratification, will be speaking about "Crystal Ball Medicine" at HLTH in Las Vegas this week. At the event, Chamoun, an experienced health tech entrepreneur, w…
AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design Â
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been recognized as the global leader in hardware for fleet management and digitalization, taking the #1 position in the Wialon GPS Hardware Manufacturers Top 10: 2025 edition. The award was announced at the annual …
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typi…
WUHU, China, Oct. 19, 2025 /PRNewswire/ -- At the 2025 Chery Global Innovation Conference, an extraordinary "guest" took the stage — Mornine, the intelligent robot from AiMOGA Robotics.
NEW YORK, Oct. 18, 2025 /PRNewswire/ --
LUOYANG, China, Oct. 18, 2025 /PRNewswire/ -- On October 17, the 6th International Ancient Capitals Forum kicked off in Luoyang City, Henan Province. The event was attended by more than 150 participants, including government officials, experts and scholars, and international organization rep…
Fast-growing express car wash operator plans to hire 450 new team members across six states, offering competitive pay, profit sharing, and clear career paths
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblas…
First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder cancerUnprecedented survival results from pivotal Phase 3 EV-303 trial show potential for PADCEV plus KEYTRUDA to redefine stand…
NEW YORK, Oct. 18, 2025 /PRNewswire/ --
NEW YORK, Oct. 18, 2025 /PRNewswire/ --
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- According to Sichuan International Communication Center, on October 17 (Beijing time), the "Sichuan Ease" cultural tourism logo made its global debut simultaneously across five landmark locations worldwide, including Times Square in New York, Wes…
HONG KONG, Oct. 18, 2025 /PRNewswire/ -- The second phase of the Global Sources Hong Kong Shows opened today at AsiaWorld-Expo, running from October 18 to 21. The four-day event combines four major trade shows: the Mobile Electronics, Smart Home, Security & Home Appliances, Lifestyle, an…
Underscores MorseLife's exceptional workplace culture and enduring commitment to purpose-driven senior care
Florida Cancer Specialists & Research Institute Shaping the Future of Cancer Care at Global Congress
Oral Presentation to be Featured on Initial Results of a First-in-Human Study for a Promising Targeted Therapy for Advanced/Metastatic Solid Tumors.
SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases and their associated cancers, announced the presentation of first-in-human clinical data for SCG142 in an investi…
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- The 138th China Import and Export Fair (Canton Fair), taking place from October 15 to November 4 in Guangzhou, is strengthening its role as a key platform for global commerce through end-to-end attendance services and full-chain trade services,…
The first-of-its-kind brunch united influential women, including author and TV personality Porsha Williams, "Good Morning America's" Janai Norman, and NBC4 New York/WNBC's Natalie Pasquarella for heartfelt conversations about maternal and infant health.
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
HICKSVILLE, N.Y., Oct. 17, 2025 /PRNewswire/ -- Flagstar Bank, N.A. (NYSE: FLG)Â today announced the completion of its previously approved holding company reorganization, effective at the close of business on October 17, 2025, a step that simplifies the corporate structure, reduces regulatory…
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
Inventor of VR Perimetry Now Powers the Industry's Most Trusted and Clinically Validated Platform for Automated Eye Care.
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
DiCello Levitt, Hausfeld, Hecht Partners, and Zuckerman Spaeder Win Class Action Bellwether Trial Against Global Banking Giant BNP Paribas for Violating U.S. Sanctions By Financing and Supporting Sudan Atrocities
Rybelsus® (semaglutide) tablets 7 mg or 14 mg, the only FDA-approved oral GLP-1 medicine available, now indicated to reduce the risk of major adverse cardiovascular events (MACE) such as CV death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events1In…
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
LD Micro Main Event XIX, October 19-21, 2025
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
NEW YORK, Oct. 17, 2025 /PRNewswire/ --
NEW YORK, Oct. 17, 2025 /PRNewswire/ --